FDA Approved: VYLOY — Supplemental Application (Astellas Pharma US, Inc.)

View source ↗

Summary

FDA approved a supplemental application for VYLOY (zolbetuximab) from Astellas Pharma US, expanding/updating its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• VYLOY (ZOLBETUXIMAB)

Snippet

SUPPL AP for VYLOY (ZOLBETUXIMAB)